Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00857922 · ClinicalTrials.gov registry record
Neurosciences Research Repository
A clinical trial of Neurological Conditions, sponsored by The University of Texas Health Science Center, Houston.
- Recruiting
- Registry status
- 15,000
- Enrollment target
- 1
- Study location
NCT00857922: Recruiting study of Neurological Conditions, sponsored by The University of Texas Health Science Center, Houston.
NCT00857922 is a study of Neurological Conditions that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 15,000 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00857922, a study of Neurological Conditions, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.
- RECRUITING
- Registry status
- 15,000 participants
- Enrollment target
- 1
- Study location
Study Summary
In order to expand neuroscience research and move laboratory advances to patients, there is a need to integrate reliable clinical data with biologic information from patient tissue specimens. The Neuroscience Research Repository (NRR) seeks to meet this need. The NRR is a prospective database and sample bank created to collect information and samples for current and future neuroscience research. The objective of this NRR is to develop a data and sample repository for study of neurological conditions. A repository utilizing standardized electronic health data and samples collected in a uniform manner serves to foster the ability to perform research on current and future projects. Samples and data for clinical, genomic and proteomic analysis will be provided to optimize their value for neuroscience research. The NRR will enroll patients and collect clinically recorded longitudinal data for as long as they are followed by the Neurosurgery service and up to an additional 5 years after being released from care. Patients will be enrolled on admission to the service and samples will be taken at three time points: Time One, within 24 hours of event (preferably first blood draw); Time Two, within 48 hours of event; and Time Three, time of any residual tissue availability. Family members of select groups of patients will also be approached for enrollment. Samples and data will be labeled with a study code to maintain confidentiality. Samples and data will be maintained in secure, limited access environments with back-up/redundancy procedures in place. Sample inventory will be maintained with a bar-coding system. A duty to warn clause will be included in the consent as will the determination of willingness to be re-contacted for future research. Time of sample acquisition to time of sample processing will be documented for quality control purposes. Freezers will be monitored for temperature stability. Recipient investigators will be requested to provide feedback on sample qu
Primary Outcome
Standardized functional outcome score
Conditions Studied
Interventions
- OTHER tissue and data repository
Study Locations (1)
Texas
- Memorial Hermann Hospital - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15,000 participants |
| Start Date | 2009-03 |
| Est. Completion | 2030-08 |
What NCT00857922 shows while recruiting
NCT00857922 is an observational study that tracks outcomes without assigning an intervention. Its 15,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Neurological Conditions appearing as the primary indexed condition, and to 1 intervention - of which tissue and data repository is the first listed.
NCT00857922 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00857922 about?
NCT00857922 is a clinical study titled "Neurosciences Research Repository". In order to expand neuroscience research and move laboratory advances to patients, there is a need to integrate reliable clinical data with biologic information from patient tissue specimens. The Neuroscience Research Repository (NRR) seeks to meet this need. The NRR is a prospective database and sa...
What is the current status of trial NCT00857922?
This trial is currently recruiting. The enrollment target is 15,000 participants. The study started on 2009-03. Estimated completion is 2030-08.
What conditions does trial NCT00857922 study?
This clinical trial studies the following conditions: Neurological Conditions.
What interventions are being tested in trial NCT00857922?
The interventions under investigation include: tissue and data repository (OTHER).
Who is sponsoring clinical trial NCT00857922?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00857922 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neurological Conditions
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01137643 · 15,000 participants
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
- NCT01550575 · 15,000 participants
Patient Retrospective Outcomes (PRO)
- NCT02253251 · 15,000 participants
Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment
- NCT03050762 · 15,000 participants
Comprehensive Data Collection and Follow-Up for Patients With Thyroid, Parathyroid and Adrenal Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia